核心观点公司发布2024H1 业绩公告，上半年实现收入23.82 亿元，同比+35.4%；实现净利润3.85 亿元，同比增长15.1%；实现经调整利润4.01 亿元，同比+15.5%，业绩增长略低于预期。公司公告在公开市场回购股份不超过价值2 亿元，彰显出其对自身中长期发展的信心。随着公司新投用床位使用率逐步爬坡，内生收入增速有望保持稳定，加上去年收购的3 家医院贡献增量、实现较好的经营改善，公司...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.